CM Life Sciences II Inc.

CM Life Sciences II Inc. (Nasdaq: SLGC) is a blank-check company sponsored by CM Life Sciences, a firm with a dedicated focus on life sciences and healthcare investing. The SPAC completed its initial public offering in 2021, targeting acquisition opportunities across biotechnology, diagnostics, and healthcare technology. On December 1, 2023, the company filed a Definitive Proxy Statement on Merger or Acquisition (DEFM14A) with the SEC, signaling that it had advanced to the shareholder-approval stage of a proposed business combination. The December 2023 filing placed SLGC among a cohort of life sciences SPACs navigating deal closings in a tightened post-boom market environment. Sign up at SpacDesk for full sponsor history, filing timelines, and deal data on CM Life Sciences II and hundreds of other SPACs.